| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | voltage-gated sodium channel activity | 1.81e-13 | 26 | 90 | 8 | GO:0005248 | |
| GeneOntologyMolecularFunction | sodium channel activity | 7.93e-11 | 52 | 90 | 8 | GO:0005272 | |
| GeneOntologyMolecularFunction | sodium ion binding | 3.22e-09 | 14 | 90 | 5 | GO:0031402 | |
| GeneOntologyMolecularFunction | alkali metal ion binding | 1.01e-07 | 26 | 90 | 5 | GO:0031420 | |
| GeneOntologyMolecularFunction | sodium ion transmembrane transporter activity | 1.05e-06 | 171 | 90 | 8 | GO:0015081 | |
| GeneOntologyMolecularFunction | monoatomic cation channel activity | 2.44e-05 | 343 | 90 | 9 | GO:0005261 | |
| GeneOntologyMolecularFunction | voltage-gated monoatomic ion channel activity involved in regulation of presynaptic membrane potential | 5.75e-05 | 17 | 90 | 3 | GO:0099508 | |
| GeneOntologyMolecularFunction | monoatomic ion channel activity | 2.25e-04 | 459 | 90 | 9 | GO:0005216 | |
| GeneOntologyMolecularFunction | metal ion transmembrane transporter activity | 2.48e-04 | 465 | 90 | 9 | GO:0046873 | |
| GeneOntologyMolecularFunction | channel activity | 5.99e-04 | 525 | 90 | 9 | GO:0015267 | |
| GeneOntologyMolecularFunction | passive transmembrane transporter activity | 6.07e-04 | 526 | 90 | 9 | GO:0022803 | |
| GeneOntologyMolecularFunction | voltage-gated monoatomic ion channel activity | 1.40e-03 | 182 | 90 | 5 | GO:0005244 | |
| GeneOntologyMolecularFunction | voltage-gated channel activity | 1.47e-03 | 184 | 90 | 5 | GO:0022832 | |
| GeneOntologyBiologicalProcess | membrane depolarization during action potential | 1.94e-10 | 36 | 91 | 7 | GO:0086010 | |
| GeneOntologyBiologicalProcess | cardiac muscle cell action potential involved in contraction | 1.04e-08 | 62 | 91 | 7 | GO:0086002 | |
| GeneOntologyBiologicalProcess | neuronal action potential | 1.16e-08 | 63 | 91 | 7 | GO:0019228 | |
| GeneOntologyBiologicalProcess | cardiac muscle cell action potential | 1.13e-07 | 87 | 91 | 7 | GO:0086001 | |
| GeneOntologyBiologicalProcess | cardiac muscle cell contraction | 1.79e-07 | 93 | 91 | 7 | GO:0086003 | |
| GeneOntologyBiologicalProcess | actin filament-based movement | 3.85e-07 | 153 | 91 | 8 | GO:0030048 | |
| GeneOntologyBiologicalProcess | transmission of nerve impulse | 6.40e-07 | 112 | 91 | 7 | GO:0019226 | |
| GeneOntologyBiologicalProcess | membrane depolarization | 1.08e-06 | 121 | 91 | 7 | GO:0051899 | |
| GeneOntologyBiologicalProcess | actin-mediated cell contraction | 1.50e-06 | 127 | 91 | 7 | GO:0070252 | |
| GeneOntologyBiologicalProcess | sodium ion transport | 3.53e-06 | 275 | 91 | 9 | GO:0006814 | |
| GeneOntologyBiologicalProcess | sodium ion transmembrane transport | 3.88e-06 | 208 | 91 | 8 | GO:0035725 | |
| GeneOntologyBiologicalProcess | heart contraction | 6.76e-06 | 298 | 91 | 9 | GO:0060047 | |
| GeneOntologyBiologicalProcess | heart process | 9.04e-06 | 309 | 91 | 9 | GO:0003015 | |
| GeneOntologyBiologicalProcess | cardiac muscle contraction | 9.20e-06 | 167 | 91 | 7 | GO:0060048 | |
| GeneOntologyBiologicalProcess | action potential | 3.05e-05 | 201 | 91 | 7 | GO:0001508 | |
| GeneOntologyBiologicalProcess | striated muscle contraction | 4.96e-05 | 217 | 91 | 7 | GO:0006941 | |
| GeneOntologyBiologicalProcess | muscle contraction | 6.84e-05 | 400 | 91 | 9 | GO:0006936 | |
| GeneOntologyBiologicalProcess | response to pain | 7.56e-05 | 51 | 91 | 4 | GO:0048265 | |
| GeneOntologyBiologicalProcess | positive regulation of renal sodium excretion | 1.15e-04 | 4 | 91 | 2 | GO:0035815 | |
| GeneOntologyBiologicalProcess | blood circulation | CACNA1B GPR4 NPR1 DRD2 SCN1A SCN2A SCN3A SCN4A SCN8A SCN9A SCN10A | 1.31e-04 | 648 | 91 | 11 | GO:0008015 |
| GeneOntologyBiologicalProcess | actin filament-based process | MYO3A KISS1R MYO1C SCN1A SCN2A SCN3A SCN4A SCN8A SCN9A OBSCN SCN10A PDXP OBSL1 | 1.78e-04 | 912 | 91 | 13 | GO:0030029 |
| GeneOntologyBiologicalProcess | positive regulation of DNA damage checkpoint | 1.91e-04 | 5 | 91 | 2 | GO:2000003 | |
| GeneOntologyBiologicalProcess | behavioral response to pain | 3.76e-04 | 32 | 91 | 3 | GO:0048266 | |
| GeneOntologyBiologicalProcess | circulatory system process | CACNA1B GPR4 NPR1 DRD2 SCN1A SCN2A SCN3A SCN4A SCN8A SCN9A SCN10A | 3.78e-04 | 733 | 91 | 11 | GO:0003013 |
| GeneOntologyBiologicalProcess | negative regulation of toll-like receptor 2 signaling pathway | 3.99e-04 | 7 | 91 | 2 | GO:0034136 | |
| GeneOntologyBiologicalProcess | regulation of renal sodium excretion | 5.30e-04 | 8 | 91 | 2 | GO:0035813 | |
| GeneOntologyBiologicalProcess | negative regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction | 5.71e-04 | 86 | 91 | 4 | GO:0051898 | |
| GeneOntologyCellularComponent | voltage-gated sodium channel complex | 4.76e-13 | 17 | 92 | 7 | GO:0001518 | |
| GeneOntologyCellularComponent | sodium channel complex | 3.66e-11 | 29 | 92 | 7 | GO:0034706 | |
| GeneOntologyCellularComponent | cation channel complex | 9.36e-06 | 235 | 92 | 8 | GO:0034703 | |
| GeneOntologyCellularComponent | monoatomic ion channel complex | 4.35e-05 | 378 | 92 | 9 | GO:0034702 | |
| GeneOntologyCellularComponent | TTT Hsp90 cochaperone complex | 5.73e-05 | 3 | 92 | 2 | GO:0110078 | |
| GeneOntologyCellularComponent | node of Ranvier | 8.91e-05 | 20 | 92 | 3 | GO:0033268 | |
| GeneOntologyCellularComponent | intercalated disc | 2.31e-04 | 68 | 92 | 4 | GO:0014704 | |
| GeneOntologyCellularComponent | axon initial segment | 2.77e-04 | 29 | 92 | 3 | GO:0043194 | |
| GeneOntologyCellularComponent | transmembrane transporter complex | 4.94e-04 | 523 | 92 | 9 | GO:1902495 | |
| GeneOntologyCellularComponent | transporter complex | 7.08e-04 | 550 | 92 | 9 | GO:1990351 | |
| GeneOntologyCellularComponent | cell-cell contact zone | 7.92e-04 | 94 | 92 | 4 | GO:0044291 | |
| GeneOntologyCellularComponent | axon | CACNA1B DRD2 NRTN SIGMAR1 SCN1A SCN2A SCN3A SCN4A SCN8A SCN9A SCN10A | 1.83e-03 | 891 | 92 | 11 | GO:0030424 |
| HumanPheno | Impulsivity | CACNA1B GLDC SCN1A SCN2A SCN3A SCN8A SCN9A TTI1 SRCAP DALRD3 | 6.00e-08 | 149 | 37 | 10 | HP:0100710 |
| HumanPheno | Complex febrile seizure | 4.03e-06 | 16 | 37 | 4 | HP:0011172 | |
| HumanPheno | Tibial torsion | 1.89e-05 | 23 | 37 | 4 | HP:0100694 | |
| HumanPheno | Photosensitive myoclonic seizure | 1.93e-05 | 8 | 37 | 3 | HP:0001327 | |
| HumanPheno | Cyanotic episode | 1.93e-05 | 8 | 37 | 3 | HP:0200048 | |
| HumanPheno | Focal hemiclonic seizure | 2.67e-05 | 25 | 37 | 4 | HP:0006813 | |
| HumanPheno | Simple febrile seizure | 3.67e-05 | 27 | 37 | 4 | HP:0011171 | |
| HumanPheno | Erythromelalgia | 4.09e-05 | 10 | 37 | 3 | HP:0032147 | |
| HumanPheno | Limited neck range of motion | 5.59e-05 | 11 | 37 | 3 | HP:0000466 | |
| HumanPheno | Epilepsia partialis continua | 7.42e-05 | 12 | 37 | 3 | HP:0012847 | |
| HumanPheno | Focal automatism seizure | 7.42e-05 | 12 | 37 | 3 | HP:0032898 | |
| HumanPheno | Status epilepticus | 9.06e-05 | 207 | 37 | 8 | HP:0002133 | |
| HumanPheno | Generalized clonic seizure | 9.35e-05 | 34 | 37 | 4 | HP:0011169 | |
| HumanPheno | Generalized cerebral atrophy/hypoplasia | 9.60e-05 | 13 | 37 | 3 | HP:0007058 | |
| HumanPheno | Rigidity | 1.14e-04 | 214 | 37 | 8 | HP:0002063 | |
| HumanPheno | Facial tics | 1.51e-04 | 15 | 37 | 3 | HP:0011468 | |
| HumanPheno | Photosensitive tonic-clonic seizure | 1.51e-04 | 15 | 37 | 3 | HP:0007207 | |
| HumanPheno | Dysgenesis of the hippocampus | 1.85e-04 | 16 | 37 | 3 | HP:0025101 | |
| HumanPheno | Focal clonic seizure | 2.17e-04 | 42 | 37 | 4 | HP:0002266 | |
| HumanPheno | Myoclonus | 2.18e-04 | 371 | 37 | 10 | HP:0001336 | |
| HumanPheno | Focal motor status epilepticus | 2.24e-04 | 17 | 37 | 3 | HP:0032663 | |
| HumanPheno | Atypical absence status epilepticus | 2.24e-04 | 17 | 37 | 3 | HP:0011151 | |
| HumanPheno | Clonic seizure | 2.63e-04 | 81 | 37 | 5 | HP:0020221 | |
| HumanPheno | Visually-induced seizure | 2.67e-04 | 18 | 37 | 3 | HP:0020216 | |
| HumanPheno | Generalized non-convulsive status epilepticus without coma | 2.67e-04 | 18 | 37 | 3 | HP:0032860 | |
| HumanPheno | Abnormal hippocampus morphology | 3.65e-04 | 48 | 37 | 4 | HP:0025100 | |
| HumanPheno | Non-convulsive status epilepticus without coma | 3.69e-04 | 20 | 37 | 3 | HP:0032671 | |
| HumanPheno | EEG with abnormally slow frequencies | 3.87e-04 | 88 | 37 | 5 | HP:0011203 | |
| HumanPheno | Abnormal morphology of the limbic system | 3.95e-04 | 49 | 37 | 4 | HP:0007343 | |
| HumanPheno | Talipes valgus | 4.29e-04 | 21 | 37 | 3 | HP:0004684 | |
| HumanPheno | Reflex seizure | 4.94e-04 | 22 | 37 | 3 | HP:0020207 | |
| HumanPheno | EEG with multifocal slow activity | 4.97e-04 | 52 | 37 | 4 | HP:0010844 | |
| HumanPheno | Neonatal electro-clinical non-motor seizure | 5.06e-04 | 5 | 37 | 2 | HP:0032812 | |
| HumanPheno | Neonatal seizure with electrographic correlate | 5.06e-04 | 5 | 37 | 2 | HP:0032808 | |
| HumanPheno | Neonatal electro-clinical seizure | 5.06e-04 | 5 | 37 | 2 | HP:0032809 | |
| HumanPheno | Neonatal electro-clinical seizure with behavior arrest | 5.06e-04 | 5 | 37 | 2 | HP:0032823 | |
| HumanPheno | Focal head nodding automatism seizure | 5.06e-04 | 5 | 37 | 2 | HP:0032906 | |
| HumanPheno | Allodynia | 5.06e-04 | 5 | 37 | 2 | HP:0012533 | |
| HumanPheno | Weakness of the intrinsic hand muscles | 6.43e-04 | 24 | 37 | 3 | HP:0009005 | |
| HumanPheno | Pes valgus | 6.61e-04 | 56 | 37 | 4 | HP:0008081 | |
| HumanPheno | Abnormality of the calcaneus | 7.07e-04 | 57 | 37 | 4 | HP:0008364 | |
| HumanPheno | Intellectual disability, borderline | 7.27e-04 | 25 | 37 | 3 | HP:0006889 | |
| HumanPheno | Normal interictal EEG | 7.56e-04 | 6 | 37 | 2 | HP:0002372 | |
| HumanPheno | Aggressive behavior | CACNA1B GLDC SCN1A SCN2A SCN3A TTI2 SCN8A SCN9A TTI1 SRCAP DALRD3 | 7.62e-04 | 516 | 37 | 11 | HP:0000718 |
| HumanPheno | Abnormal aggressive, impulsive or violent behavior | CACNA1B GLDC SCN1A SCN2A SCN3A TTI2 SCN8A SCN9A TTI1 SRCAP DALRD3 | 7.62e-04 | 516 | 37 | 11 | HP:0006919 |
| HumanPheno | Compulsive behaviors | 8.48e-04 | 158 | 37 | 6 | HP:0000722 | |
| HumanPheno | Limited knee extension | 9.15e-04 | 27 | 37 | 3 | HP:0003066 | |
| HumanPheno | Status epilepticus without prominent motor symptoms | 9.15e-04 | 27 | 37 | 3 | HP:0031475 | |
| HumanPheno | Reduced tendon reflexes | CACNA1B FBXO38 SIGMAR1 GLDC SCN3A SCN4A SCN8A SCN9A OBSCN SCN10A SMPD1 DALRD3 | 9.37e-04 | 617 | 37 | 12 | HP:0001315 |
| HumanPheno | Focal aware seizure | 1.02e-03 | 28 | 37 | 3 | HP:0002349 | |
| HumanPheno | Eyelid myoclonia seizure | 1.05e-03 | 7 | 37 | 2 | HP:0032678 | |
| HumanPheno | Generalized tonic seizure | 1.10e-03 | 64 | 37 | 4 | HP:0010818 | |
| HumanPheno | Athetosis | 1.10e-03 | 166 | 37 | 6 | HP:0002305 | |
| HumanPheno | Status epilepticus with prominent motor symptoms | 1.13e-03 | 29 | 37 | 3 | HP:0032658 | |
| HumanPheno | Limb myoclonus | 1.13e-03 | 29 | 37 | 3 | HP:0045084 | |
| HumanPheno | Multifocal epileptiform discharges | 1.23e-03 | 66 | 37 | 4 | HP:0010841 | |
| HumanPheno | Progressive gait ataxia | 1.25e-03 | 30 | 37 | 3 | HP:0007240 | |
| HumanPheno | Progressive ataxia | 1.25e-03 | 30 | 37 | 3 | HP:0001329 | |
| MousePheno | impaired behavioral response to alcohol | 1.80e-05 | 10 | 76 | 3 | MP:0009755 | |
| MousePheno | abnormal single cell response | 3.72e-05 | 35 | 76 | 4 | MP:0003463 | |
| Domain | Na_channel_asu | 6.11e-15 | 10 | 91 | 7 | IPR001696 | |
| Domain | Na_trans_assoc | 6.11e-15 | 10 | 91 | 7 | IPR010526 | |
| Domain | Na_trans_assoc | 6.11e-15 | 10 | 91 | 7 | PF06512 | |
| Domain | Channel_four-helix_dom | 7.66e-12 | 57 | 91 | 9 | IPR027359 | |
| Domain | - | 7.66e-12 | 57 | 91 | 9 | 1.20.120.350 | |
| Domain | Na_trans_cytopl | 1.47e-11 | 6 | 91 | 5 | PF11933 | |
| Domain | Na_trans_cytopl | 1.47e-11 | 6 | 91 | 5 | IPR024583 | |
| Domain | IQ_motif_EF-hand-BS | MYO3A MYO1C SCN1A SCN2A SCN3A SCN4A SCN8A SCN9A OBSCN SCN10A | 1.89e-11 | 90 | 91 | 10 | IPR000048 |
| Domain | IQ | MYO3A MYO1C SCN1A SCN2A SCN3A SCN4A SCN8A SCN9A OBSCN SCN10A | 2.63e-11 | 93 | 91 | 10 | PS50096 |
| Domain | IQ | 6.00e-11 | 71 | 91 | 9 | PF00612 | |
| Domain | IQ | 2.02e-10 | 81 | 91 | 9 | SM00015 | |
| Domain | Ion_trans_dom | 4.41e-09 | 114 | 91 | 9 | IPR005821 | |
| Domain | Ion_trans | 4.41e-09 | 114 | 91 | 9 | PF00520 | |
| Domain | EF-hand-dom_pair | 5.06e-04 | 287 | 91 | 7 | IPR011992 | |
| Domain | - | 9.78e-04 | 321 | 91 | 7 | 3.80.10.10 | |
| Domain | L_dom-like | 1.11e-03 | 328 | 91 | 7 | IPR032675 | |
| Domain | LRRNT | 1.34e-03 | 98 | 91 | 4 | IPR000372 | |
| Domain | LRRNT | 1.34e-03 | 98 | 91 | 4 | SM00013 | |
| Domain | LRR_8 | 1.50e-03 | 171 | 91 | 5 | PF13855 | |
| Domain | Leu-rich_rpt_typical-subtyp | 1.74e-03 | 177 | 91 | 5 | IPR003591 | |
| Domain | LRR_TYP | 1.74e-03 | 177 | 91 | 5 | SM00369 | |
| Domain | Leu-rich_rpt | 2.10e-03 | 271 | 91 | 6 | IPR001611 | |
| Domain | LRRNT | 2.20e-03 | 53 | 91 | 3 | PF01462 | |
| Domain | FN3 | 2.90e-03 | 199 | 91 | 5 | PS50853 | |
| Domain | LRR | 3.02e-03 | 201 | 91 | 5 | PS51450 | |
| Domain | FN3_dom | 3.57e-03 | 209 | 91 | 5 | IPR003961 | |
| Domain | LRR_1 | 4.35e-03 | 219 | 91 | 5 | PF00560 | |
| Domain | - | 5.56e-03 | 23 | 91 | 2 | 3.30.530.20 | |
| Domain | START-like_dom | 5.56e-03 | 23 | 91 | 2 | IPR023393 | |
| Pathway | REACTOME_INTERACTION_BETWEEN_L1_AND_ANKYRINS | 5.43e-11 | 31 | 62 | 7 | M877 | |
| Pathway | REACTOME_PHASE_0_RAPID_DEPOLARISATION | 6.93e-11 | 32 | 62 | 7 | M27455 | |
| Pathway | REACTOME_CARDIAC_CONDUCTION | 9.38e-08 | 130 | 62 | 8 | M27454 | |
| Pathway | REACTOME_L1CAM_INTERACTIONS | 9.59e-07 | 121 | 62 | 7 | M872 | |
| Pathway | REACTOME_MUSCLE_CONTRACTION | 2.80e-06 | 203 | 62 | 8 | M5485 | |
| Pathway | WP_DRAVET_SYNDROME | 6.42e-06 | 28 | 62 | 4 | M45519 | |
| Pathway | REACTOME_NERVOUS_SYSTEM_DEVELOPMENT | NRTN SCN1A SCN2A SCN3A SCN4A CYP51A1 SCN8A SCN9A SCN10A EPHA10 | 1.87e-04 | 575 | 62 | 10 | M29853 |
| Pathway | WP_ADHD_AND_AUTISM_ASD_PATHWAYS | 1.94e-04 | 367 | 62 | 8 | M48346 | |
| Pubmed | 2.78e-17 | 9 | 93 | 7 | 16382098 | ||
| Pubmed | A 'toothache tree' alkylamide inhibits Aδ mechanonociceptors to alleviate mechanical pain. | 3.10e-16 | 6 | 93 | 6 | 23652591 | |
| Pubmed | 5.24e-13 | 13 | 93 | 6 | 15123669 | ||
| Pubmed | 1.53e-11 | 9 | 93 | 5 | 15746173 | ||
| Pubmed | 4.79e-11 | 4 | 93 | 4 | 17537961 | ||
| Pubmed | 4.79e-11 | 4 | 93 | 4 | 35031483 | ||
| Pubmed | 4.79e-11 | 4 | 93 | 4 | 29578003 | ||
| Pubmed | 2.39e-10 | 5 | 93 | 4 | 8812438 | ||
| Pubmed | 2.39e-10 | 5 | 93 | 4 | 17724025 | ||
| Pubmed | 1.85e-08 | 3 | 93 | 3 | 19284629 | ||
| Pubmed | 1.85e-08 | 3 | 93 | 3 | 12610651 | ||
| Pubmed | 1.85e-08 | 3 | 93 | 3 | 33895391 | ||
| Pubmed | 1.85e-08 | 3 | 93 | 3 | 23859570 | ||
| Pubmed | 1.85e-08 | 3 | 93 | 3 | 19699781 | ||
| Pubmed | 1.85e-08 | 3 | 93 | 3 | 18784617 | ||
| Pubmed | 1.85e-08 | 3 | 93 | 3 | 17544618 | ||
| Pubmed | 1.85e-08 | 3 | 93 | 3 | 32845893 | ||
| Pubmed | 1.85e-08 | 3 | 93 | 3 | 28518218 | ||
| Pubmed | 1.85e-08 | 3 | 93 | 3 | 17928448 | ||
| Pubmed | 1.85e-08 | 3 | 93 | 3 | 14973256 | ||
| Pubmed | Nav1.2 haplodeficiency in excitatory neurons causes absence-like seizures in mice. | 2.33e-08 | 12 | 93 | 4 | 30175250 | |
| Pubmed | Confirmation of quantitative trait loci for alcohol preference in mice. | 6.39e-08 | 15 | 93 | 4 | 9726281 | |
| Pubmed | 7.39e-08 | 4 | 93 | 3 | 21156207 | ||
| Pubmed | 7.39e-08 | 4 | 93 | 3 | 22260870 | ||
| Pubmed | 7.39e-08 | 4 | 93 | 3 | 35801810 | ||
| Pubmed | Use of recombinant inbred strains for studying genetic determinants of responses to alcohol. | 7.39e-08 | 4 | 93 | 3 | 8974318 | |
| Pubmed | Large-scale analysis of ion channel gene expression in the mouse heart during perinatal development. | 9.95e-08 | 139 | 93 | 7 | 16985003 | |
| Pubmed | 1.84e-07 | 5 | 93 | 3 | 1679748 | ||
| Pubmed | Early development of electrical excitability in the mouse enteric nervous system. | 1.84e-07 | 5 | 93 | 3 | 22875929 | |
| Pubmed | 1.84e-07 | 5 | 93 | 3 | 24337656 | ||
| Pubmed | 3.68e-07 | 6 | 93 | 3 | 16029194 | ||
| Pubmed | 3.68e-07 | 6 | 93 | 3 | 23711479 | ||
| Pubmed | Diagnostic yield of genetic testing in epileptic encephalopathy in childhood. | 6.43e-07 | 7 | 93 | 3 | 25818041 | |
| Pubmed | Pain without nociceptors? Nav1.7-independent pain mechanisms. | 6.43e-07 | 7 | 93 | 3 | 24440715 | |
| Pubmed | 1.03e-06 | 8 | 93 | 3 | 25101983 | ||
| Pubmed | LMBR1L regulates lymphopoiesis through Wnt/β-catenin signaling. | THEM6 CNNM3 ATAD3B POM121 SIGMAR1 TTI2 CLPTM1 CYP51A1 PDXP OBSL1 SRP68 GALNT12 VPS51 | 1.37e-06 | 942 | 93 | 13 | 31073040 |
| Pubmed | Genetic mapping of the peripheral sodium channel genes, Scn9a and Scn10a, in the mouse. | 1.54e-06 | 9 | 93 | 3 | 8854872 | |
| Pubmed | 4.00e-06 | 12 | 93 | 3 | 8169823 | ||
| Pubmed | 7.07e-06 | 2 | 93 | 2 | 29649454 | ||
| Pubmed | 7.07e-06 | 2 | 93 | 2 | 20346423 | ||
| Pubmed | Reduction of Kcnt1 is therapeutic in mouse models of SCN1A and SCN8A epilepsy. | 7.07e-06 | 2 | 93 | 2 | 37901435 | |
| Pubmed | 7.07e-06 | 2 | 93 | 2 | 18079277 | ||
| Pubmed | An Scn1a epilepsy mutation in Scn8a alters seizure susceptibility and behavior. | 7.07e-06 | 2 | 93 | 2 | 26410685 | |
| Pubmed | Neuronal death and perinatal lethality in voltage-gated sodium channel alpha(II)-deficient mice. | 7.07e-06 | 2 | 93 | 2 | 10827969 | |
| Pubmed | 7.07e-06 | 2 | 93 | 2 | 19694741 | ||
| Pubmed | 7.07e-06 | 2 | 93 | 2 | 35348308 | ||
| Pubmed | Genomic structures of SCN2A and SCN3A - candidate genes for deafness at the DFNA16 locus. | 7.07e-06 | 2 | 93 | 2 | 11245985 | |
| Pubmed | Neuropathic pain develops normally in mice lacking both Na(v)1.7 and Na(v)1.8. | 7.07e-06 | 2 | 93 | 2 | 16111501 | |
| Pubmed | 7.07e-06 | 2 | 93 | 2 | 15760941 | ||
| Pubmed | Differential expression of two sodium channel subtypes in human brain. | 7.07e-06 | 2 | 93 | 2 | 1317301 | |
| Pubmed | Duplication of the sodium channel gene cluster on 2q24 in children with early onset epilepsy. | 7.07e-06 | 2 | 93 | 2 | 23016767 | |
| Pubmed | Cocaine inhibits dopamine D2 receptor signaling via sigma-1-D2 receptor heteromers. | 7.07e-06 | 2 | 93 | 2 | 23637801 | |
| Pubmed | 7.07e-06 | 2 | 93 | 2 | 27153334 | ||
| Pubmed | 7.07e-06 | 2 | 93 | 2 | 33096315 | ||
| Pubmed | Electrophysiological Differences between the Same Pore Region Mutation in SCN1A and SCN3A. | 7.07e-06 | 2 | 93 | 2 | 24990319 | |
| Pubmed | Na+ current properties in islet α- and β-cells reflect cell-specific Scn3a and Scn9a expression. | 7.07e-06 | 2 | 93 | 2 | 25172946 | |
| Pubmed | Sigma-1 Receptor Plays a Negative Modulation on N-type Calcium Channel. | 7.07e-06 | 2 | 93 | 2 | 28603497 | |
| Pubmed | 7.07e-06 | 2 | 93 | 2 | 31439038 | ||
| Pubmed | Sodium channel expression within chronic multiple sclerosis plaques. | 7.07e-06 | 2 | 93 | 2 | 17805013 | |
| Pubmed | 7.07e-06 | 2 | 93 | 2 | 26311622 | ||
| Pubmed | 7.07e-06 | 2 | 93 | 2 | 33411788 | ||
| Pubmed | 7.07e-06 | 2 | 93 | 2 | 31943325 | ||
| Pubmed | Severe epilepsy, retardation, and dysmorphic features with a 2q deletion including SCN1A and SCN2A. | 7.07e-06 | 2 | 93 | 2 | 15249644 | |
| Pubmed | 7.07e-06 | 2 | 93 | 2 | 27690330 | ||
| Pubmed | Sodium channel slow inactivation interferes with open channel block. | 7.07e-06 | 2 | 93 | 2 | 27174182 | |
| Pubmed | 7.07e-06 | 2 | 93 | 2 | 21377452 | ||
| Pubmed | 7.07e-06 | 2 | 93 | 2 | 18601978 | ||
| Pubmed | Correlations in timing of sodium channel expression, epilepsy, and sudden death in Dravet syndrome. | 7.07e-06 | 2 | 93 | 2 | 23965409 | |
| Pubmed | FGF14 N-terminal splice variants differentially modulate Nav1.2 and Nav1.6-encoded sodium channels. | 7.07e-06 | 2 | 93 | 2 | 19465131 | |
| Pubmed | Persistent Nav1.1 and Nav1.6 currents drive spinal locomotor functions through nonlinear dynamics. | 7.07e-06 | 2 | 93 | 2 | 37665666 | |
| Pubmed | 7.07e-06 | 2 | 93 | 2 | 17881658 | ||
| Pubmed | 7.07e-06 | 2 | 93 | 2 | 30693367 | ||
| Pubmed | Block of a subset of sodium channels exacerbates experimental autoimmune encephalomyelitis. | 7.07e-06 | 2 | 93 | 2 | 23735284 | |
| Pubmed | A dual-activity topoisomerase complex regulates mRNA translation and turnover. | CCND3 PITPNM2 SH2B3 MFHAS1 SGSM2 NBEAL2 SCN8A OBSCN SNAPC4 SRCAP BIRC6 PKN3 NOD2 | 7.74e-06 | 1105 | 93 | 13 | 35748872 |
| Pubmed | 2.12e-05 | 3 | 93 | 2 | 28784306 | ||
| Pubmed | 2.12e-05 | 3 | 93 | 2 | 32185219 | ||
| Pubmed | 2.12e-05 | 3 | 93 | 2 | 32005694 | ||
| Pubmed | The cell and molecular basis of mechanical, cold, and inflammatory pain. | 2.12e-05 | 3 | 93 | 2 | 18669863 | |
| Pubmed | 2.12e-05 | 3 | 93 | 2 | 22449024 | ||
| Pubmed | 2.12e-05 | 3 | 93 | 2 | 31098411 | ||
| Pubmed | Sodium channel Na(v)1.7 is essential for lowering heat pain threshold after burn injury. | 2.12e-05 | 3 | 93 | 2 | 22875917 | |
| Pubmed | 2.12e-05 | 3 | 93 | 2 | 16033895 | ||
| Pubmed | Role of sodium channel subtype in action potential generation by neocortical pyramidal neurons. | 2.12e-05 | 3 | 93 | 2 | 29991598 | |
| Pubmed | 2.12e-05 | 3 | 93 | 2 | 20038812 | ||
| Pubmed | 2.12e-05 | 3 | 93 | 2 | 28074005 | ||
| Pubmed | 2.12e-05 | 3 | 93 | 2 | 27816501 | ||
| Pubmed | Role of the hippocampus in Nav1.6 (Scn8a) mediated seizure resistance. | 2.12e-05 | 3 | 93 | 2 | 24704313 | |
| Pubmed | Structural insight into M-band assembly and mechanics from the titin-obscurin-like-1 complex. | 2.12e-05 | 3 | 93 | 2 | 20133654 | |
| Pubmed | 2.12e-05 | 3 | 93 | 2 | 19270815 | ||
| Pubmed | 2.12e-05 | 3 | 93 | 2 | 16052353 | ||
| Pubmed | 2.12e-05 | 3 | 93 | 2 | 38999942 | ||
| Pubmed | 2.12e-05 | 3 | 93 | 2 | 15314237 | ||
| Pubmed | 2.12e-05 | 3 | 93 | 2 | 25155934 | ||
| Pubmed | The sorting receptor Rer1 controls Purkinje cell function via voltage gated sodium channels. | 2.12e-05 | 3 | 93 | 2 | 28117367 | |
| Pubmed | Conditional knockout of NaV1.6 in adult mice ameliorates neuropathic pain. | 2.12e-05 | 3 | 93 | 2 | 29497094 | |
| Pubmed | Yield of peripheral sodium channels gene screening in pure small fibre neuropathy. | 2.12e-05 | 3 | 93 | 2 | 30554136 | |
| Pubmed | Nerve injury induces robust allodynia and ectopic discharges in Nav1.3 null mutant mice. | 2.12e-05 | 3 | 93 | 2 | 17052333 | |
| Pubmed | 2.12e-05 | 3 | 93 | 2 | 38514708 | ||
| Pubmed | 2.12e-05 | 3 | 93 | 2 | 26182346 | ||
| Pubmed | De novo SCN1A, SCN8A, and CLCN2 mutations in childhood absence epilepsy. | 2.12e-05 | 3 | 93 | 2 | 31054517 | |
| Interaction | SCN11A interactions | 4.60e-09 | 15 | 90 | 5 | int:SCN11A | |
| Interaction | CACNA1B interactions | 6.18e-07 | 37 | 90 | 5 | int:CACNA1B | |
| Interaction | SCN5A interactions | 2.10e-06 | 47 | 90 | 5 | int:SCN5A | |
| Interaction | CACNA1D interactions | 3.69e-06 | 24 | 90 | 4 | int:CACNA1D | |
| Interaction | SCN4B interactions | 4.75e-06 | 8 | 90 | 3 | int:SCN4B | |
| Interaction | SCN1A interactions | 8.11e-06 | 29 | 90 | 4 | int:SCN1A | |
| Interaction | NALCN interactions | 3.03e-05 | 14 | 90 | 3 | int:NALCN | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr2q24 | 1.35e-04 | 127 | 93 | 4 | chr2q24 | |
| Cytoband | 2q24 | 2.21e-04 | 11 | 93 | 2 | 2q24 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr19p13 | 2.22e-04 | 797 | 93 | 8 | chr19p13 | |
| Cytoband | 2q24.3 | 4.78e-04 | 16 | 93 | 2 | 2q24.3 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr9q34 | 5.39e-04 | 325 | 93 | 5 | chr9q34 | |
| Cytoband | 19q13.3 | 6.35e-04 | 82 | 93 | 3 | 19q13.3 | |
| Cytoband | 3p21.31 | 1.13e-03 | 100 | 93 | 3 | 3p21.31 | |
| Cytoband | 9q34.3 | 1.33e-03 | 106 | 93 | 3 | 9q34.3 | |
| GeneFamily | Sodium voltage-gated channel alpha subunits | 1.58e-16 | 9 | 63 | 7 | 1203 | |
| GeneFamily | TTT complex | 3.58e-05 | 3 | 63 | 2 | 1320 | |
| ToppCell | 368C-Endothelial_cells-Endothelial-B_(Artery)-|368C / Donor, Lineage, Cell class and subclass (all cells) | 7.89e-08 | 173 | 93 | 7 | ec88e871b49331fca59bc610a8ae58e2d5e76bc1 | |
| ToppCell | 368C-Endothelial_cells-Endothelial-B_(Artery)|368C / Donor, Lineage, Cell class and subclass (all cells) | 7.89e-08 | 173 | 93 | 7 | 22200fe74e33e2beae0eed289ca8476bbc0b1b2d | |
| ToppCell | facs-Brain_Non-Myeloid-Cortex-24m|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.29e-07 | 186 | 93 | 7 | 7278a1a1bf9bb27aeb03852134defb31b62f30d6 | |
| ToppCell | Fetal_29-31_weeks-Epithelial-lung_neuroendocrine_cell_(PNEC)-D150|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 2.77e-06 | 188 | 93 | 6 | c4c3b21ab723b0e9beff9ec84f8d68485f771528 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_principal_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.86e-06 | 189 | 93 | 6 | 3a295c215b5c18e7c673f92b7af5be523421682c | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_principal_cell-Degenerative_Outer_Medullary_Collecting_Duct_Principal_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 3.13e-06 | 192 | 93 | 6 | 0bb06738e1c3ec0c044a7ee61f6cf1d4781fb53c | |
| ToppCell | facs-Brain_Non-Myeloid-Cortex-24m-Neuronal|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.22e-06 | 193 | 93 | 6 | be28070c049e7cb68bcd54f582226eb2f5e4bc1c | |
| ToppCell | facs-Brain_Non-Myeloid-Cortex-24m-Neuronal-nan|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.22e-06 | 193 | 93 | 6 | 0c652ebe22ce5d2927599dd97ef1920547858395 | |
| ToppCell | facs-Brain_Non-Myeloid-Cortex-24m-Neuronal-neuron|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.22e-06 | 193 | 93 | 6 | 8689a70a33a7c3823dc647d41ac0160e7c3ae396 | |
| ToppCell | (6)_Endothelial-B_(Artery)|World / Lung cell shreds - cell class (v4) and cell subclass (v4) | 3.32e-06 | 194 | 93 | 6 | 0cf4e67d4024652794b5bfdd4a71a7d98900b4c8 | |
| ToppCell | proximal-Endothelial-Capillary-3|proximal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 3.63e-06 | 197 | 93 | 6 | ddb8ea895f0f34d4f20a0740b708fa0f3e378801 | |
| ToppCell | proximal-Endothelial-Capillary|proximal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 3.63e-06 | 197 | 93 | 6 | 53baef54bd85c60ae24a3c163b3a3d937fb6ff0b | |
| ToppCell | proximal-3-Endothelial-Capillary|3 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 3.63e-06 | 197 | 93 | 6 | a1a61c03d67272693ec23e0d15f0a12bf618e2da | |
| ToppCell | cellseq-Endothelial-Endothelial_Vascular-Endothelial_large_blood_vessel-AEC|cellseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 3.63e-06 | 197 | 93 | 6 | 56afed433887cb2766eb30f22aec195148db33ab | |
| ToppCell | 3'-Parenchyma_lung-Endothelial-Blood_vessel_EC-pulmonary_artery_endothelial_cell-EC_arterial|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.73e-06 | 198 | 93 | 6 | 1b9200e30f1d9b91bb0c6411c4f95208aedbe161 | |
| ToppCell | 3'-Parenchyma_lung-Endothelial-Blood_vessel_EC-pulmonary_artery_endothelial_cell|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.73e-06 | 198 | 93 | 6 | 7e2d6e21b2b3d5a4a9f786890ec6ba2688a506cc | |
| ToppCell | 3'-Parenchyma_lung-Endothelial-Blood_vessel_EC-pulmonary_artery_endothelial_cell-EC_arterial-EC_arterial_L.2.4.0.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.73e-06 | 198 | 93 | 6 | 55378e15360f867c9500b03293814965562ae55d | |
| ToppCell | Fetal_brain-fetalBrain_Zhong_nature-GW26|fetalBrain_Zhong_nature / Sample Type, Dataset, Time_group, and Cell type. | 3.96e-06 | 200 | 93 | 6 | 61d7dd0a78942b069c3f5e75044368dc00e6e8e6 | |
| ToppCell | Lung_Parenchyma-Control-Endothelial-Endothelial-Artery-|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 3.96e-06 | 200 | 93 | 6 | 622206c33640cb2694fe158e8dc55515bb7bd4f5 | |
| ToppCell | Parenchyma_COVID-19-Endothelial-TX-Artery|Parenchyma_COVID-19 / Sample group, Lineage and Cell type | 3.96e-06 | 200 | 93 | 6 | 34b279804475ea58fbb052b96f44128c082627a9 | |
| ToppCell | Lung_Parenchyma-Control-Endothelial-Endothelial-Artery|Control / Location, Disease Group, Cell group, Cell class (2021.03.09) | 3.96e-06 | 200 | 93 | 6 | 5b4a54cd81bc4d9f5e92798362239e1aa1b70bee | |
| ToppCell | Lung_Parenchyma-Severe-Endothelial-Endothelial-Artery|Severe / Location, Disease Group, Cell group, Cell class (2021.03.09) | 3.96e-06 | 200 | 93 | 6 | 8552cc7a439449b30b59760c3e8667217b9852b5 | |
| ToppCell | Parenchyma_Control_(B.)-Endothelial-TX-Artery|Parenchyma_Control_(B.) / Sample group, Lineage and Cell type | 3.96e-06 | 200 | 93 | 6 | 590d1c0f86f136c7e76ea107fbb8ac5ff1164386 | |
| ToppCell | Lung_Parenchyma-Severe-Endothelial-Endothelial-Artery-|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 3.96e-06 | 200 | 93 | 6 | 45c08f1befe78553bbadcc2fcffb6138306638f3 | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Distal_tubule_epithelial_cell-kidney_distal_convoluted_tubule_epithelial_cell-Distal_Convoluted_Tubule_Cell_Type_1|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 8.51e-06 | 132 | 93 | 5 | 295980f70645ee2934145e9959c01f999044da3e | |
| ToppCell | remission-unassigned|World / disease stage, cell group and cell class | 1.85e-05 | 155 | 93 | 5 | d81bec894381e3e2d6249a567e8108b8423e5c54 | |
| ToppCell | 367C-Lymphocytic-CD8+_Cytotoxic_T-cell-CD8+_Cytotoxic_T_cell_3|367C / Donor, Lineage, Cell class and subclass (all cells) | 2.16e-05 | 160 | 93 | 5 | ab633295cb4de88fdbc076295e1352769f47cc00 | |
| ToppCell | COVID-CD8-exh_CD4|COVID / Condition, Cell_class and T cell subcluster | 2.57e-05 | 166 | 93 | 5 | 4ca8c91b03d08489f244898cf9423b9d10348bc8 | |
| ToppCell | 356C-Endothelial_cells-Endothelial-B_(Artery)|356C / Donor, Lineage, Cell class and subclass (all cells) | 2.80e-05 | 169 | 93 | 5 | 605cc2638271803cf1d972ab3fa8f13f89666376 | |
| ToppCell | 356C-Endothelial_cells-Endothelial-B_(Artery)-|356C / Donor, Lineage, Cell class and subclass (all cells) | 2.80e-05 | 169 | 93 | 5 | 337be3bf485b54afad86e256cb0c4c1d0c2a9a2a | |
| ToppCell | Fetal_29-31_weeks-Endothelial-endothelial_cell_of_artery-D062|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 3.05e-05 | 172 | 93 | 5 | de9b11ab109d04937186c09772cec9105a935f95 | |
| ToppCell | 3'-GW_trimst-1.5-SmallIntestine-Neuronal-Glial_immature-ENCC/glia_Progenitor|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.14e-05 | 173 | 93 | 5 | 23e50492bc673aff9df95d97f0b9be4ce57cbf01 | |
| ToppCell | droplet-Fat-Bat-18m-Mesenchymal-nan|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.31e-05 | 175 | 93 | 5 | b4f01e7782cdd107d0817ef601891fd3a382bc35 | |
| ToppCell | droplet-Fat-Bat-18m-Mesenchymal-mesenchymal_stem_cell_of_adipose|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.31e-05 | 175 | 93 | 5 | ef6f811d8e1839f405c3b41090ddf79be57a099f | |
| ToppCell | droplet-Fat-Bat-18m-Mesenchymal|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.31e-05 | 175 | 93 | 5 | 7f7598d46d10bff1cbea42f950bdde1aaa16e9a4 | |
| ToppCell | PCW_13-14-Neuronal-Neuronal_postreplicative-neuro_neuronal_(6)|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 3.69e-05 | 179 | 93 | 5 | af0b54c9ea0b6e4210f22dbb6e88ecd3276a5f86 | |
| ToppCell | 5'-GW_trimst-2-SmallIntestine-Epithelial-neuro-epithelial-EC_cells_(TAC1+)|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.79e-05 | 180 | 93 | 5 | 6b1606238417490e0d9930870a7827419d1c3737 | |
| ToppCell | Epithelial-lung_neuroendocrine_cell_(PNEC)|World / Lineage, Cell type, age group and donor | 3.99e-05 | 182 | 93 | 5 | 57bf4ffb304324e2e392e196336a530d9f78fe0d | |
| ToppCell | PND07-Epithelial-Epithelial_Airway-Neurosecretory-PNEC|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 4.21e-05 | 184 | 93 | 5 | 3e5c68a99c10eb1ddc1048bea4aa9f6b8e2746ff | |
| ToppCell | PND07-Epithelial-Epithelial_Airway-Neurosecretory-PNEC-PNEC_mature|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 4.21e-05 | 184 | 93 | 5 | 1e2f0cec50475a1cf2973a5082826bbc60fc9a68 | |
| ToppCell | 3'-GW_trimst-1.5-LargeIntestine-Endothelial-blood_vessel_EC-Fetal_arterial_EC|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 4.32e-05 | 185 | 93 | 5 | 602536a3308a848f106adcb0a83530997440c8f4 | |
| ToppCell | droplet-Heart-nan-18m-Endothelial|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.32e-05 | 185 | 93 | 5 | a32d5cb596ebac80eb1ac301055e65d420879ec8 | |
| ToppCell | Fetal_29-31_weeks-Epithelial-lung_neuroendocrine_cell_(PNEC)|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 4.43e-05 | 186 | 93 | 5 | b45cce768e4bf91da194fd9660cab7520dfb15ac | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_principal_cell-Outer_Medullary_Collecting_Duct_Principal_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 4.54e-05 | 187 | 93 | 5 | e3095455d2f255854f339f6b05fa87852af0700f | |
| ToppCell | LPS-IL1RA+antiTNF-Endothelial-Endothelial-Alv_Cap|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 4.66e-05 | 188 | 93 | 5 | 73f6ec915934154f435a376cb274b058ff7c5f35 | |
| ToppCell | Substantia_nigra-Neuronal-Inhibitory-iN1(Gad1Gad2_Th)|Substantia_nigra / BrainAtlas - Mouse McCarroll V32 | 4.66e-05 | 188 | 93 | 5 | b73e8a40393c3f656e2fcfe395a761b1f985c254 | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Epithelial-Collecting_tubule_epithelial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 4.78e-05 | 189 | 93 | 5 | 532aaf02b364c5c4f58a2021c7c21d86df3875c9 | |
| ToppCell | LPS-IL1RA+antiTNF-Endothelial-Endothelial-Alv_Gen_Intermediate|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 4.90e-05 | 190 | 93 | 5 | a3c6eec6df052105ab78b7e3c78f94218d5912eb | |
| ToppCell | facs-Trachea-3m-Endothelial-endothelial_cell_of_trachea-tracheal_endothelial_cell-tracheal_endothelial_cell_l10|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 4.90e-05 | 190 | 93 | 5 | 2655df8c0883dd811fa7617301f9c4b0a4dd55ec | |
| ToppCell | 15-Trachea-Epithelial-Neuroendocrine|Trachea / Age, Tissue, Lineage and Cell class | 5.02e-05 | 191 | 93 | 5 | 76311fa5f3ae9bb27cf04387a8c92300f2888c28 | |
| ToppCell | COPD-Endothelial-VE_Arterial|Endothelial / Disease state, Lineage and Cell class | 5.02e-05 | 191 | 93 | 5 | ef16ad1c1cd2c0c0377957398c98775b62a81754 | |
| ToppCell | LPS-antiTNF-Endothelial-Endothelial-Activated_Alv_Cap|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 5.15e-05 | 192 | 93 | 5 | c618ede75dce3988c87a5b8f98d8e94e1dd66efd | |
| ToppCell | IPF-Endothelial-VE_Arterial|Endothelial / Disease state, Lineage and Cell class | 5.15e-05 | 192 | 93 | 5 | e911e286da26202853f9650ba3cdefe5a5c9b585 | |
| ToppCell | PCW_07-8.5-Endothelial-Endothelial_cycling-endo_proliferating2_(14)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 5.15e-05 | 192 | 93 | 5 | ac3d87aa301d30515c369bd7fc16f33b82173a85 | |
| ToppCell | facs-Brain_Non-Myeloid-Cortex-3m-Neuronal-neuron|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.28e-05 | 193 | 93 | 5 | 461919ab422bc9d1fcff7a3a4757c75239041d7e | |
| ToppCell | facs-Brain_Non-Myeloid-Cortex-3m-Neuronal-nan|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.28e-05 | 193 | 93 | 5 | 0dd810ad900d3e586551622b2c1de39d76fd6a7f | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell-Adaptive_/_Maladaptive_/_Repairing_Thick_Ascending_Limb_Cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 5.28e-05 | 193 | 93 | 5 | f42a0f02ed00fe1bb833ff0a0640d9131bca89bd | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_principal_cell-Degenerative_Outer_Medullary_Collecting_Duct_Principal_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 5.28e-05 | 193 | 93 | 5 | e7012f7b53971972299db34fa51ff51a4e4987fe | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 5.28e-05 | 193 | 93 | 5 | 42df7ed37d11fb542b4d1d714b6f87ae8e1396a6 | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_principal_cell-Degenerative_Outer_Medullary_Collecting_Duct_Principal_Cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 5.41e-05 | 194 | 93 | 5 | be869e186386d03ebb670971dd24fa656b4b0edf | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_principal_cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 5.41e-05 | 194 | 93 | 5 | 4d6c9b016e3a0641954a8ea10c97d1cd76fadd9f | |
| ToppCell | droplet-Bladder-Unstain-18m-Endothelial-endothelial_cell|Bladder / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.41e-05 | 194 | 93 | 5 | 9d7cbbcf995274019ca10be0562f114513ec197a | |
| ToppCell | droplet-Bladder-Unstain-18m-Endothelial|Bladder / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.54e-05 | 195 | 93 | 5 | fbfe4a8ae9775764108b45920eec92003b24fb2e | |
| ToppCell | proximal-Endothelial-Capillary_Aerocyte|proximal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 5.54e-05 | 195 | 93 | 5 | f1cbf82484f489fe7e0b5de6a49ea28d69f04e1a | |
| ToppCell | proximal-Endothelial-Capillary_Aerocyte-3|proximal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 5.54e-05 | 195 | 93 | 5 | 13168c9632b58dd65ecb365df3832d95e7325919 | |
| ToppCell | droplet-Bladder-Unstain-18m-Endothelial-endothelial_cell|Bladder / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.54e-05 | 195 | 93 | 5 | 2a6056172c41c46acfe0242be22269ef1d07921e | |
| ToppCell | proximal-3-Endothelial-Capillary_Aerocyte|3 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 5.54e-05 | 195 | 93 | 5 | 36b2e754ed7ff138ac05fb51f4494e5339669828 | |
| ToppCell | Somatosensory_Cortex_(S1)-Neuronal|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 5.96e-05 | 198 | 93 | 5 | c01091ef18e096d792ea2a7a715764a5b215355f | |
| ToppCell | Parenchymal-NucSeq-Epithelial-Epi_airway_neuro-secretory-Neuroendocrine|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 5.96e-05 | 198 | 93 | 5 | 8f25e8dff42bad8e779ca618bdb1cb1610667962 | |
| ToppCell | primary_auditory_cortex_(A1C)-Neuronal|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 5.96e-05 | 198 | 93 | 5 | 6d18b45eda4014759e6dd282d78ffd28df8a6044 | |
| ToppCell | 5'-Adult-Distal_Rectal-Endothelial-blood_vessel_EC-Mature_arterial_EC|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 5.96e-05 | 198 | 93 | 5 | 8a55589b9244283e4b0b423a4a6d6202e8e0fec9 | |
| ToppCell | Primary_Motor_Cortex_(M1)-Neuronal|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 5.96e-05 | 198 | 93 | 5 | 4ca5ff320905ab4ff60ed90a5522227c782142a6 | |
| ToppCell | Parenchymal-NucSeq-Epithelial-Epi_airway_neuro-secretory|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 5.96e-05 | 198 | 93 | 5 | e3e0aa3ef20b2370f5b133048510677aaa562dfa | |
| ToppCell | TCGA-Testes-Primary_Tumor-Testicular_Germ_Cell_Tumor-Testicular_Germ_Cell_Tumor-1|TCGA-Testes / Sample_Type by Project: Shred V9 | 5.99e-05 | 101 | 93 | 4 | d1112a5edda7da38f454a15a0b8b25180099510c | |
| ToppCell | Tracheal-10x3prime_v2-Endothelial-Endothelia_vascular-VE_systemic_arterial|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations | 6.10e-05 | 199 | 93 | 5 | bd43a84e84d8acb8e1008b98a235cc5bd5f43586 | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Endothelial-Endothelial_mature-Endo_capilar-A|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 6.10e-05 | 199 | 93 | 5 | c5c12c8288fe868322bae9d691b91fee953ceb3e | |
| ToppCell | Tracheal-10x3prime_v2-Endothelial-Endothelia_vascular-VE_pulmonary_arterial|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations | 6.10e-05 | 199 | 93 | 5 | fff88d2bba262583bb726900ae01e44954b72eb9 | |
| ToppCell | distal-2-Endothelial-Artery|2 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 6.10e-05 | 199 | 93 | 5 | fa8aaf7a90699e41a7a4cee5614f8c9248110327 | |
| ToppCell | Transverse-Macrophage-LYVE1_Macrophage|Macrophage / Region, Cell class and subclass | 6.10e-05 | 199 | 93 | 5 | fd75dccb37d96448edf72b7d042b06833d4ead24 | |
| ToppCell | distal-Endothelial-Artery-2|distal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 6.10e-05 | 199 | 93 | 5 | 3788f3218356aaaa10684e48d63757037f8a3a3c | |
| ToppCell | Parenchymal-10x5prime-Endothelial-Endothelia_vascular-VE_pulmonary_arterial|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 6.25e-05 | 200 | 93 | 5 | ac6b8bc9998d303f788511b8f111e682ea9f3df8 | |
| ToppCell | Bronchial-10x5prime-Endothelial-Endothelia_vascular-VE_capillary|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 6.25e-05 | 200 | 93 | 5 | 5ab588808c1fc384019413401ab4bf9bc06bf529 | |
| ToppCell | LPS_anti-TNF-Endothelial-Endothelial-Alv_Cap|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 6.25e-05 | 200 | 93 | 5 | 66f7e8ee63c828f17468e79a4b816346b33e8980 | |
| ToppCell | LPS_IL1RA_TNF-Endothelial-Endothelial|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 6.25e-05 | 200 | 93 | 5 | a1fa6bae5a688faf488d6925cd3fad725dfa916b | |
| ToppCell | LPS_anti-TNF-Endothelial|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 6.25e-05 | 200 | 93 | 5 | 1d105eeda5a2c51f9a4654ffc79b7e2348ad593b | |
| ToppCell | LPS_IL1RA_TNF-Endothelial|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 6.25e-05 | 200 | 93 | 5 | d01cec331be3b03cef80e9536fc531285bcf00f6 | |
| ToppCell | LPS_anti-TNF-Endothelial-Endothelial|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 6.25e-05 | 200 | 93 | 5 | 60d2cbf41f37f1b11eddb4c9d9246c9c1fc5a5af | |
| ToppCell | Fetal_brain-organoid_Tanaka_cellReport-GW26|organoid_Tanaka_cellReport / Sample Type, Dataset, Time_group, and Cell type. | 6.25e-05 | 200 | 93 | 5 | 5c7263c862093ad9dbc81d06b16b6f74e8a6b634 | |
| ToppCell | Frontal_cortex-Neuronal-Inhibitory-iN2(Gad1Gad2)-Cplx3|Frontal_cortex / BrainAtlas - Mouse McCarroll V32 | 6.72e-05 | 104 | 93 | 4 | b5ca6e589f414e549f4990fe334d4ee54829b298 | |
| ToppCell | PND07-28-samps-Myeloid-Macrophage-macrophage-A|PND07-28-samps / Age Group, Lineage, Cell class and subclass | 8.96e-05 | 112 | 93 | 4 | d21cfcb04a27cc9fb74e0c2afa8a8cdfb886ae21 | |
| ToppCell | facs-Brain_Non-Myeloid-Striatum-24m-Macroglial-astrocyte|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.29e-04 | 123 | 93 | 4 | a45d6907c041ad3f3218cd46dccfc25d4bd961cb | |
| ToppCell | TCGA-Lung-Primary_Tumor-Lung_Carcinoma-Lung_Adenocarcinoma_Mixed_Subtype-6|TCGA-Lung / Sample_Type by Project: Shred V9 | 1.41e-04 | 126 | 93 | 4 | b49b15ba1458488f98d54e87100257a12ee34076 | |
| ToppCell | Hippocampus-Endothelial-ENDOTHELIAL_STALK|Hippocampus / BrainAtlas - Mouse McCarroll V32 | 2.06e-04 | 139 | 93 | 4 | 34398a6f21a1e670497655a7bb7f3cde9e117560 | |
| ToppCell | Hippocampus-Endothelial-ENDOTHELIAL_STALK-Flt1_2|Hippocampus / BrainAtlas - Mouse McCarroll V32 | 2.06e-04 | 139 | 93 | 4 | 450c4152c9fe4ec503271bb3cf93739918c59509 | |
| ToppCell | Hippocampus-Neuronal-Inhibitory-iN1(Gad1Gad2_Th)-Prlr-Inhibitory_Gad1Gad2_Id2.Prlr_(Interneuron,_Neurogliaform3)|Hippocampus / BrainAtlas - Mouse McCarroll V32 | 2.07e-04 | 55 | 93 | 3 | 948f26841f18d2d45f74c7c0c7b5be10737a4f43 | |
| ToppCell | Hippocampus-Neuronal-Inhibitory-iN1(Gad1Gad2_Th)-Prlr|Hippocampus / BrainAtlas - Mouse McCarroll V32 | 2.07e-04 | 55 | 93 | 3 | 616be3c334949ab0264293b9771d494381d74fb4 | |
| ToppCell | Hippocampus-Neuronal-Inhibitory-iN1(Gad1Gad2_Th)-Prlr-Inhibitory_Gad1Gad2_Id2.Prlr_(Interneuron,_Neurogliaform3)-|Hippocampus / BrainAtlas - Mouse McCarroll V32 | 2.07e-04 | 55 | 93 | 3 | ed14bdb80cf2ff171b0dfc391ac0b150da344992 | |
| ToppCell | LPS-antiTNF-Endothelial-Epi-like|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.36e-04 | 144 | 93 | 4 | 75b16adfbe84f69376e6566d531ba7919d5c5192 | |
| ToppCell | Cerebellum-Endothelial-ENDOTHELIAL_STALK-Flt1_1|Cerebellum / BrainAtlas - Mouse McCarroll V32 | 2.42e-04 | 145 | 93 | 4 | 37580218f6a6f65a1d827cbcf59465f8827f9a55 | |
| ToppCell | facs-Lung-Endomucin-24m-Endothelial-Capillary_Type_1_Cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.42e-04 | 145 | 93 | 4 | 96712c68ab759d7ade0d912581a1a7c25dc6def8 | |
| Drug | APETx1, Anthopleura elegantissima | 5.77e-12 | 6 | 92 | 5 | ctd:C475726 | |
| Drug | Zonisamide | 5.75e-09 | 17 | 92 | 5 | DB00909 | |
| Drug | isradipine | 7.16e-09 | 100 | 92 | 8 | CID000003784 | |
| Drug | dihydrochloride | 1.67e-08 | 159 | 92 | 9 | CID000070978 | |
| Drug | 2,3,5,6-tetrafluoro-4-methylbenzyl (Z)-(1RS)-cis-3-(2-chloro-3,3,3-trifluoroprop-1-enyl)-2,2-dimethylcyclopropanecarboxylate | 1.73e-08 | 8 | 92 | 4 | ctd:C489827 | |
| Drug | tetradotoxin | CACNA1B NPR1 DRD2 SIGMAR1 SCN2A SCN3A SCN4A SCN8A SCN9A SCN10A PTGER1 PKN3 NOD2 | 1.77e-08 | 428 | 92 | 13 | CID000020382 |
| Drug | N-(2-methyl-3-(4-(4-(4-(trifluoromethoxy)benzyloxy)piperidin-1-yl)-1,3,5-triazin-2-ylamino)phenyl)acetamide | 6.38e-08 | 3 | 92 | 3 | ctd:C561228 | |
| Drug | APETx2 protein, Anthopleura elegantissima | 2.55e-07 | 4 | 92 | 3 | ctd:C501880 | |
| Drug | GBR 12909 | 3.60e-07 | 69 | 92 | 6 | CID000003455 | |
| Drug | benzocaine | 3.80e-07 | 37 | 92 | 5 | CID000002337 | |
| Drug | lamotrigine | 4.55e-07 | 116 | 92 | 7 | CID000003878 | |
| Drug | CAS 298-57-7 | 5.05e-07 | 73 | 92 | 6 | CID000002761 | |
| Drug | 1, 3-diallylurea | 5.48e-07 | 74 | 92 | 6 | CID000074537 | |
| Drug | Tetrodotoxin | 5.68e-07 | 40 | 92 | 5 | ctd:D013779 | |
| Drug | verapamil | CACNA1B MYO3A DRD2 TPCN2 SCN3A SCN4A SCN9A SCN10A PDXP VPS51 BIRC6 PKN3 | 6.58e-07 | 490 | 92 | 12 | CID000002520 |
| Drug | Scorpion Venoms | 7.31e-07 | 18 | 92 | 4 | ctd:D012604 | |
| Drug | bupivacaine | 7.55e-07 | 125 | 92 | 7 | CID000002474 | |
| Drug | bepridil | 7.97e-07 | 126 | 92 | 7 | CID000002351 | |
| Drug | diprafenone | 9.24e-07 | 19 | 92 | 4 | CID000071249 | |
| Drug | spiradoline | 1.16e-06 | 46 | 92 | 5 | CID000005620 | |
| Drug | Sodium | 1.16e-06 | 84 | 92 | 6 | ctd:D012964 | |
| Drug | fenpropathrin | 1.27e-06 | 6 | 92 | 3 | ctd:C044267 | |
| Drug | clenbuterol | 1.78e-06 | 142 | 92 | 7 | CID000002783 | |
| Drug | decamethrin | 2.14e-06 | 146 | 92 | 7 | ctd:C017180 | |
| Drug | propafenone | 2.88e-06 | 98 | 92 | 6 | CID000004932 | |
| Drug | procaine | 2.93e-06 | 153 | 92 | 7 | CID000004914 | |
| Drug | AC1NT1AF | 2.96e-06 | 25 | 92 | 4 | CID005322157 | |
| Drug | phenytoin | 3.00e-06 | 219 | 92 | 8 | CID000001775 | |
| Drug | Pirmenolum | 3.49e-06 | 26 | 92 | 4 | CID000004853 | |
| Drug | PbTx-1 | 4.08e-06 | 27 | 92 | 4 | CID006437089 | |
| Drug | AC1L1MOZ | 4.08e-06 | 27 | 92 | 4 | CID000031958 | |
| Drug | nefopam | 4.08e-06 | 27 | 92 | 4 | CID000004450 | |
| Drug | GTP[S] | CACNA1B GPR4 NPR1 DRD2 TPCN2 SIGMAR1 SCN3A SCN4A SCN9A SCN10A PTGER1 PKN3 | 4.59e-06 | 591 | 92 | 12 | CID000001764 |
| Drug | paraben | 4.75e-06 | 28 | 92 | 4 | CID000007175 | |
| Drug | tocainide | 6.31e-06 | 30 | 92 | 4 | CID000038945 | |
| Drug | saxitoxin | 6.58e-06 | 65 | 92 | 5 | CID000037165 | |
| Drug | nifedipine | CACNA1B MYO3A NPR1 TPCN2 CYP51A1 SMPD1 BIRC6 PKN3 CYP2W1 NOD2 | 6.92e-06 | 415 | 92 | 10 | CID000004485 |
| Drug | mexiletine | 7.10e-06 | 66 | 92 | 5 | CID000004178 | |
| Drug | dibucaine | 8.23e-06 | 68 | 92 | 5 | CID000003025 | |
| Drug | NSC93767 | 8.23e-06 | 32 | 92 | 4 | CID000005658 | |
| Drug | NSC7524 | 9.18e-06 | 182 | 92 | 7 | CID000005657 | |
| Drug | hydrochlorothiazide | 9.31e-06 | 120 | 92 | 6 | CID000003639 | |
| Drug | 5-hydroxypropafenone | 1.06e-05 | 34 | 92 | 4 | CID000107927 | |
| Drug | sipatrigine | 1.49e-05 | 37 | 92 | 4 | CID000060803 | |
| Drug | isoproterenol | CACNA1B MYO3A NPR1 DRD2 MYO1C SCN3A SCN4A SCN9A SCN10A SMPD1 PTGER1 PKN3 | 1.59e-05 | 669 | 92 | 12 | CID000003779 |
| Drug | Bupivacaine | 1.62e-05 | 2 | 92 | 2 | DB00297 | |
| Drug | mu-conotoxin KIIIA, Conus kinoshitai | 1.62e-05 | 2 | 92 | 2 | ctd:C502265 | |
| Drug | aprindine | 1.66e-05 | 38 | 92 | 4 | CID000002218 | |
| Drug | bupropion | 1.94e-05 | 81 | 92 | 5 | CID000000444 | |
| Drug | S-ropivacaine | 2.04e-05 | 40 | 92 | 4 | CID000071273 | |
| Drug | pilsicainide | 3.58e-05 | 46 | 92 | 4 | CID000004820 | |
| Drug | indoxacarb | 4.60e-05 | 49 | 92 | 4 | CID000107720 | |
| Drug | gabapentin | 6.44e-05 | 169 | 92 | 6 | CID000003446 | |
| Drug | AC1NSN3X | 6.76e-05 | 54 | 92 | 4 | CID005366189 | |
| Drug | pyraclofos | 7.09e-05 | 106 | 92 | 5 | CID000093460 | |
| Drug | riluzole | 7.57e-05 | 174 | 92 | 6 | CID000005070 | |
| Drug | fenfluramine | 8.58e-05 | 178 | 92 | 6 | CID000003337 | |
| Drug | carbamazepine | 8.85e-05 | 179 | 92 | 6 | CID000002554 | |
| Drug | triamterene | 8.96e-05 | 58 | 92 | 4 | CID000005546 | |
| Drug | Lidocaine | 9.64e-05 | 4 | 92 | 2 | DB00281 | |
| Drug | Propofol | 9.64e-05 | 4 | 92 | 2 | DB00818 | |
| Drug | Fospropofol | 9.64e-05 | 4 | 92 | 2 | DB06716 | |
| Drug | alpha-(4-fluorophenyl)-4-(5-fluoro-2-pyrimidinyl)-1-piperazine butanol | 9.64e-05 | 4 | 92 | 2 | ctd:C050408 | |
| Drug | AY9944 | 1.07e-04 | 23 | 92 | 3 | CID000009704 | |
| Drug | zonisamide | 1.16e-04 | 62 | 92 | 4 | CID000005734 | |
| Drug | ethanol | CACNA1B DRD2 SIGMAR1 SCN3A SCN4A SCN9A SCN10A PTGER1 BIRC6 F7 CYP2W1 NOD2 | 1.37e-04 | 837 | 92 | 12 | CID000000702 |
| Drug | Zalcitabine [7481-89-2]; Up 200; 19uM; MCF7; HT_HG-U133A | 1.38e-04 | 194 | 92 | 6 | 7352_UP | |
| Drug | AC1L1AY5 | 1.38e-04 | 25 | 92 | 3 | CID000001202 | |
| Drug | Multicide | 1.38e-04 | 25 | 92 | 3 | CID000024365 | |
| Drug | AC1L1CQC | 1.40e-04 | 65 | 92 | 4 | CID000002012 | |
| Drug | Tribenoside [10310-32-4]; Down 200; 8.4uM; HL60; HT_HG-U133A | 1.41e-04 | 195 | 92 | 6 | 2946_DN | |
| Drug | Diethylcarbamazine citrate [1642-54-2]; Up 200; 10.2uM; HL60; HT_HG-U133A | 1.41e-04 | 195 | 92 | 6 | 2394_UP | |
| Drug | Carcinine [56897-53-1]; Up 200; 22uM; PC3; HT_HG-U133A | 1.45e-04 | 196 | 92 | 6 | 4225_UP | |
| Drug | disopyramide | 1.49e-04 | 66 | 92 | 4 | CID000003114 | |
| Drug | resiniferatoxin | 1.49e-04 | 66 | 92 | 4 | CID000104826 | |
| Drug | Scopolamine hydrochloride [55-16-3]; Up 200; 11.8uM; MCF7; HT_HG-U133A | 1.50e-04 | 197 | 92 | 6 | 4803_UP | |
| Drug | Furaltadone hydrochloride [3759-92-0]; Down 200; 11uM; HL60; HT_HG-U133A | 1.50e-04 | 197 | 92 | 6 | 2554_DN | |
| Drug | 6-Furfurylaminopurine [525-79-1]; Up 200; 18.6uM; MCF7; HT_HG-U133A | 1.50e-04 | 197 | 92 | 6 | 6813_UP | |
| Drug | Ethoxyquin [91-53-2]; Down 200; 18.4uM; PC3; HT_HG-U133A | 1.54e-04 | 198 | 92 | 6 | 3764_DN | |
| Drug | Benzthiazide [91-33-8]; Down 200; 9.2uM; HL60; HT_HG-U133A | 1.54e-04 | 198 | 92 | 6 | 2989_DN | |
| Drug | gallopamil | 1.58e-04 | 67 | 92 | 4 | CID000001234 | |
| Drug | Nifurtimox [23256-30-6]; Up 200; 14uM; PC3; HT_HG-U133A | 1.58e-04 | 199 | 92 | 6 | 6608_UP | |
| Drug | Diflunisal [22494-42-4]; Up 200; 16uM; PC3; HT_HG-U133A | 1.58e-04 | 199 | 92 | 6 | 4210_UP | |
| Drug | Remoxipride | 1.60e-04 | 5 | 92 | 2 | DB00409 | |
| Drug | NSC-9618 | 1.60e-04 | 5 | 92 | 2 | CID000407806 | |
| Drug | cinuperone | 1.60e-04 | 5 | 92 | 2 | CID000133831 | |
| Drug | T2755 | 1.97e-04 | 71 | 92 | 4 | CID000005514 | |
| Drug | flecainide | 1.97e-04 | 71 | 92 | 4 | CID000003355 | |
| Drug | synthetic pyrethrins | 1.97e-04 | 71 | 92 | 4 | CID000002982 | |
| Drug | cyfluthrin | 2.16e-04 | 29 | 92 | 3 | ctd:C052570 | |
| Drug | imide | 2.31e-04 | 74 | 92 | 4 | CID000443040 | |
| Drug | carpipramine | 2.40e-04 | 6 | 92 | 2 | CID000002580 | |
| Drug | [11c]sa4503 | 2.40e-04 | 6 | 92 | 2 | CID009820591 | |
| Drug | diphenhydramine | 2.44e-04 | 75 | 92 | 4 | CID000003100 | |
| Drug | pentobarbital | 2.99e-04 | 224 | 92 | 6 | CID000004737 | |
| Drug | salbutamol | 3.18e-04 | 146 | 92 | 5 | CID000002083 | |
| Drug | umespirone | 3.35e-04 | 7 | 92 | 2 | CID000065902 | |
| Drug | fluorocyclobutane | 3.35e-04 | 7 | 92 | 2 | CID011051569 | |
| Drug | GR218,231 | 3.35e-04 | 7 | 92 | 2 | CID005312124 | |
| Drug | benzothiazolone | 3.35e-04 | 7 | 92 | 2 | CID000013625 | |
| Disease | generalized epilepsy with febrile seizures plus 2 (implicated_via_orthology) | 1.96e-16 | 10 | 88 | 7 | DOID:0111294 (implicated_via_orthology) | |
| Disease | Dravet syndrome (implicated_via_orthology) | 1.96e-16 | 10 | 88 | 7 | DOID:0080422 (implicated_via_orthology) | |
| Disease | generalized epilepsy with febrile seizures plus (implicated_via_orthology) | 1.29e-15 | 12 | 88 | 7 | DOID:0060170 (implicated_via_orthology) | |
| Disease | epilepsy (implicated_via_orthology) | 3.22e-08 | 163 | 88 | 8 | DOID:1826 (implicated_via_orthology) | |
| Disease | anxiety disorder (implicated_via_orthology) | 5.18e-07 | 22 | 88 | 4 | DOID:2030 (implicated_via_orthology) | |
| Disease | Generalized Epilepsy with Febrile Seizures Plus | 2.13e-06 | 9 | 88 | 3 | C3502809 | |
| Disease | Infantile Severe Myoclonic Epilepsy | 7.17e-06 | 13 | 88 | 3 | C0751122 | |
| Disease | Early Infantile Epileptic Encephalopathy 6 | 8.79e-06 | 2 | 88 | 2 | C4551549 | |
| Disease | B Virus Infection | 2.63e-05 | 3 | 88 | 2 | C0037140 | |
| Disease | Benign familial infantile epilepsy | 2.63e-05 | 3 | 88 | 2 | cv:C5575231 | |
| Disease | Postherpetic neuralgia | 2.63e-05 | 3 | 88 | 2 | C0032768 | |
| Disease | Herpesviridae Infections | 2.63e-05 | 3 | 88 | 2 | C0019372 | |
| Disease | Primary Erythermalgia | 2.63e-05 | 3 | 88 | 2 | C0014805 | |
| Disease | PAROXYSMAL EXTREME PAIN DISORDER | 2.63e-05 | 3 | 88 | 2 | C1833661 | |
| Disease | Spinal muscular atrophy, Jerash type | 8.74e-05 | 5 | 88 | 2 | C1854023 | |
| Disease | Movement Disorders | 8.85e-05 | 29 | 88 | 3 | C0026650 | |
| Disease | Familial benign neonatal epilepsy | 1.31e-04 | 6 | 88 | 2 | C0220669 | |
| Disease | Neurodevelopmental Disorders | 1.76e-04 | 93 | 88 | 4 | C1535926 | |
| Disease | Seizure, Febrile, Simple | 1.83e-04 | 7 | 88 | 2 | C0149886 | |
| Disease | Seizure, Febrile, Complex | 1.83e-04 | 7 | 88 | 2 | C0751057 | |
| Disease | Congenital Pain Insensitivity | 1.83e-04 | 7 | 88 | 2 | C0002768 | |
| Disease | Hereditary Sensory Autonomic Neuropathy, Type 5 | 1.83e-04 | 7 | 88 | 2 | C0020075 | |
| Disease | Early Childhood Epilepsy, Myoclonic | 2.43e-04 | 8 | 88 | 2 | C0393695 | |
| Disease | Idiopathic Myoclonic Epilepsy | 2.43e-04 | 8 | 88 | 2 | C0338478 | |
| Disease | Symptomatic Myoclonic Epilepsy | 2.43e-04 | 8 | 88 | 2 | C0338479 | |
| Disease | Benign Infantile Myoclonic Epilepsy | 2.43e-04 | 8 | 88 | 2 | C0751120 | |
| Disease | Myoclonic Encephalopathy | 2.43e-04 | 8 | 88 | 2 | C0438414 | |
| Disease | Myoclonic Absence Epilepsy | 2.43e-04 | 8 | 88 | 2 | C0393703 | |
| Disease | left ventricular systolic function measurement | 3.11e-04 | 44 | 88 | 3 | EFO_0008206 | |
| Disease | Febrile Convulsions | 3.12e-04 | 9 | 88 | 2 | C0009952 | |
| Disease | Myoclonic Epilepsy | 3.12e-04 | 9 | 88 | 2 | C0014550 | |
| Disease | Epilepsy | 3.24e-04 | 109 | 88 | 4 | C0014544 | |
| Disease | Epilepsy, Myoclonic, Infantile | 3.90e-04 | 10 | 88 | 2 | C0917800 | |
| Disease | Myoclonic Astatic Epilepsy | 4.75e-04 | 11 | 88 | 2 | C0393702 | |
| Disease | MMR-related febrile seizures | 9.00e-04 | 15 | 88 | 2 | EFO_0006519 | |
| Disease | Neuralgia, Supraorbital | 1.03e-03 | 16 | 88 | 2 | C0038870 | |
| Disease | Neuralgia | 1.03e-03 | 16 | 88 | 2 | C0027796 | |
| Disease | Neuralgia, Atypical | 1.03e-03 | 16 | 88 | 2 | C0234247 | |
| Disease | Neuralgia, Stump | 1.03e-03 | 16 | 88 | 2 | C0234249 | |
| Disease | Neuralgia, Iliohypogastric Nerve | 1.03e-03 | 16 | 88 | 2 | C0423712 | |
| Disease | Neuralgia, Perineal | 1.03e-03 | 16 | 88 | 2 | C0423711 | |
| Disease | Paroxysmal Nerve Pain | 1.03e-03 | 16 | 88 | 2 | C0751373 | |
| Disease | Nerve Pain | 1.03e-03 | 16 | 88 | 2 | C0751372 | |
| Disease | Neuralgia, Ilioinguinal | 1.03e-03 | 16 | 88 | 2 | C0751371 | |
| Disease | Neuralgia, Vidian | 1.03e-03 | 16 | 88 | 2 | C0042656 | |
| Disease | Early infantile epileptic encephalopathy with suppression bursts | 1.03e-03 | 16 | 88 | 2 | C0393706 | |
| Disease | aggressive behaviour measurement, ADHD symptom measurement | 1.12e-03 | 68 | 88 | 3 | EFO_0007826, EFO_0007860 | |
| Disease | Febrile seizure (within the age range of 3 months to 6 years) | 1.30e-03 | 18 | 88 | 2 | HP_0002373 | |
| Disease | diabetes mellitus (biomarker_via_orthology) | 1.45e-03 | 19 | 88 | 2 | DOID:9351 (biomarker_via_orthology) | |
| Disease | Epilepsy, Cryptogenic | 1.91e-03 | 82 | 88 | 3 | C0086237 | |
| Disease | Awakening Epilepsy | 1.91e-03 | 82 | 88 | 3 | C0751111 | |
| Disease | Aura | 1.91e-03 | 82 | 88 | 3 | C0236018 | |
| Disease | Etat Marbre | 2.14e-03 | 23 | 88 | 2 | C0266487 | |
| Disease | traumatic brain injury (biomarker_via_orthology) | 2.33e-03 | 24 | 88 | 2 | DOID:0081292 (biomarker_via_orthology) |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| QDSFSLAHPLLRRLR | 256 | Q8N6Y0 | |
| LAFILHRLSLPRDRQ | 161 | P30281 | |
| ARHVPLYRALLELLR | 4386 | Q9NR09 | |
| ARLHRIVPRLRDVFG | 71 | P17405 | |
| LRLRGVFLRHEFPRV | 906 | C9J069 | |
| RAILRTLLEARRPHV | 241 | Q8TAV3 | |
| FRHPRRLLLALRGEA | 4586 | Q96M86 | |
| ALLDAVRSFRIRHRP | 951 | P16066 | |
| FDLRTLRAVRVLRPL | 186 | Q00975 | |
| PAALLRSVRRLREVF | 11 | Q86YS3 | |
| HRLPRTLDARIARLA | 41 | Q99748 | |
| HDRTLARLSVRPRQL | 1526 | O75147 | |
| LSILRDHPENRIYRR | 16 | Q96DC9 | |
| RRRLLERGYKHPVLL | 426 | O95340 | |
| RLSIRRDRPLSVHLN | 1656 | P23467 | |
| PRLFRVASKRHRDLL | 61 | Q9Y5H6 | |
| AALRAARLRHQELFR | 356 | Q9NZM5 | |
| DPRHLRRLRDKLLSV | 631 | Q9Y4C4 | |
| NPHFRDDLRRLRPRA | 831 | Q9HBX8 | |
| LPLLLDHRTRELRAR | 126 | Q9BYJ1 | |
| RRRLHLFGRDSTIRP | 341 | Q9HCE5 | |
| HLRLRQVLSRARPSE | 381 | A0A0J9YX94 | |
| RPLLHAARVSVARAR | 141 | P34995 | |
| RLSLHGDIRLLFSRR | 496 | Q7L5A3 | |
| RARLYRQLAPHLRVD | 186 | Q11130 | |
| FPLRALHRRTPRLAL | 146 | Q969F8 | |
| LHRRTPRLALAVSLS | 151 | Q969F8 | |
| PRGSFRDLVRLRELH | 286 | P0C6S8 | |
| PLRDRLSFLHRLPIL | 6 | Q96N21 | |
| RERAATLLHLRPGAR | 406 | Q5JZY3 | |
| ASRLEPLLERRFHAL | 766 | Q9BZ72 | |
| YLAVAHPLRFARLRR | 116 | P46093 | |
| ARRLHRLFRTKSPAE | 5011 | Q5VST9 | |
| HRAFRRLRALRSLDL | 401 | Q6PEZ8 | |
| VRKARHRRTLFASPL | 96 | Q96HA1 | |
| ARLLRLYRRHEPRFP | 386 | Q86VR8 | |
| RPLTRARSRLSHVLL | 866 | Q6PIJ6 | |
| PRSHALLPRLLRADR | 466 | Q6ZSI9 | |
| RPLRLTRFDVAVRAH | 966 | Q8IZJ3 | |
| LRLSCRHLLDRDPLT | 26 | Q9UBL6 | |
| LPLPSFRRRDRAHRE | 251 | Q16850 | |
| YLSDRISLHRRLPER | 106 | Q8IXK2 | |
| RSRDFLAPHRALQAR | 36 | Q5D0E6 | |
| KRSSRAFRAHLRAPL | 226 | P14416 | |
| HLRSRLPSAIRSLIL | 6 | Q7Z3D6 | |
| RFLKHELTSELRRRP | 311 | Q52WX2 | |
| AHPLRSRVTRELRAA | 246 | Q6P5Z2 | |
| LHARTFAALSRLRRL | 126 | Q9GZU5 | |
| EHLQRALRSRFRLRL | 91 | Q9BSG5 | |
| LRFGPRRALAALVRR | 136 | Q92737 | |
| RLLKSRILFHPRSLR | 351 | Q8N3R3 | |
| LAHLSLVTPARRRLL | 41 | Q96D59 | |
| LRALRPLRALSRFEG | 1131 | P35499 | |
| RHRRSLRLLEPFEVR | 106 | Q8WUY1 | |
| HYRARVEVRLPRDLL | 1051 | Q9UFD9 | |
| HRRRRANAFLEELRP | 56 | P08709 | |
| FRRPLAQLREVHLRR | 1966 | Q6ZNJ1 | |
| LRPRRSIAFRLRLAS | 446 | Q8NEA9 | |
| LLHQLRRRAAGFLRS | 51 | O43147 | |
| TLRALRPLRALSRFE | 1291 | Q15858 | |
| LAFSRLIVELRRLHP | 56 | Q99720 | |
| LLRHDFVRRDRPLRV | 271 | Q9H2K8 | |
| LRALRPLRALSRFEG | 1306 | Q9NY46 | |
| NFPVHLSRIRRLRAE | 1546 | Q9P2P6 | |
| RTLARALHELRRFLP | 96 | Q9BRJ9 | |
| DTFLPRHRLSRRVLL | 961 | Q6ZRS2 | |
| NTEPRKRFHLLSRLR | 146 | Q9UHB9 | |
| SRRARPELALRFARL | 61 | Q96GD0 | |
| RTLRALRPLRALSRF | 1316 | P35498 | |
| ALRHPIQVSRRLLSR | 296 | Q5T9A4 | |
| RLDREHRVAGIFPRL | 441 | O96005 | |
| LRLRLRAEAVRPHSA | 101 | Q8NE01 | |
| SLLVRALDRFHRRLR | 366 | Q9UID3 | |
| ALDRFHRRLRAPGAL | 371 | Q9UID3 | |
| RRTRYPDIHLRERLA | 106 | Q9H2W2 | |
| ARDLQSHRPAIVRRL | 131 | Q9HC29 | |
| EPEHRLLLRRTYARN | 351 | Q6NXR4 | |
| TLRALRPLRALSRFE | 1251 | Q9Y5Y9 | |
| FLLIVLRRDILHRRA | 511 | Q9NXL6 | |
| RRFPHLPALLLHRRR | 106 | Q499Z4 | |
| RTLRALRPLRALSRF | 1306 | Q99250 | |
| RTLRALRPLRALSRF | 1296 | Q9UQD0 | |
| SLRHIFRRRSAGELP | 141 | Q9UQQ2 | |
| LDRHISTELRLPRRG | 456 | Q86V40 | |
| EPLRSLRILHSARAL | 526 | Q9P283 | |
| LASAVRARLARRLRP | 121 | A6NKF7 | |
| TLTFRALRRALCRLP | 16 | Q96CP7 | |
| ILDIFRGLRENRRHP | 411 | Q9UPP1 | |
| HRRLLNRRLLLAVTP | 736 | Q5SXM2 | |
| PLLLALYRSVHRARE | 456 | Q9Y2B5 | |
| LFLELIRARRPLVLH | 176 | Q96GM8 | |
| HEPLRIRRLLRPFFL | 181 | Q8NHX9 | |
| HRLTRDAPLAVLRAF | 916 | O43156 | |
| RLLERLLPRHDDFAR | 51 | P23378 | |
| TIRRLIRGFVLRHAP | 786 | O00159 | |
| ARIRRLGFSHRILFA | 981 | Q8NEV4 |